Menu
Other Links

  • Cipla faces frest RS 105-cr penalty for overcharging

    Cipla faces frest RS. 105-cr penalty for overcharging

    Attachment File: Download (52.78 KB) pdf

  • Ranbaxy-Sun Pharma deal to close by 2014 end, says Daiichi

    Ranbaxy-Sun Pharma deal to close by 2014 end, says Daiichi

    Attachment File: Download (30.04 KB) pdf

  • Ranbaxy buy triggers Sun pharma Zenotech offer

    Ranbaxy buy triggers Sun pharma's Zenotech offer

    Attachment File: Download (55.18 KB) pdf

  • FDA raids chemist seized drugs sold above statutory rate

    FDA raids chemist, seized drugs sold above statutory rate

    Attachment File: Download (21.82 KB) pdf

  • GSK swaps oncology for vaccines with Novartis

    GSK swaps oncology for vaccines with Novartis

    Attachment File: Download (65.68 KB) pdf

  • Why imported drugs are so cheap

    Why imported drugs are so cheap?

    Attachment File: Download (46.57 KB) pdf

  • Novartis-GSK Eli Lilly deal may affect Indian market

    Novartis-GSK Eli Lilly deal may affect Indian market

    Attachment File: Download (99.44 KB) pdf

  • Make essential drugs affordable for all Cipla

    Make essential drugs affordable for all: Cipla

    Attachment File: Download (86.52 KB) pdf

  • Merck to sell consumer unit for near $14 billion

    Merck to sell consumer unit for near $14 billion

    Attachment File: Download (74.26 KB) pdf

  • Drug price regulator going after major violators

    Drug price regulator going after major violators

    Attachment File: Download (43.44 KB) pdf

Pages